Nutritional strategy to prevent fatty liver and insulin resistance independent of obesity by reducing glucose-dependent insulinotropic polypeptide responses in mice

Diabetologia

Volumn 58, Issue 2, 2015, Pages 374-383

  Keyhani Nejad, Farnaz ^a,b,c   Irmler, Martin ^d   Isken, Frank ^a,b   Wirth, Eva K ^b   Beckers, Johannes ^c,d,e   Birkenfeld, Andreas L ^b,f   Pfeiffer, Andreas F H ^a,b,c  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Fatty liver; GIP response; Palatinose

Indexed keywords

FRUCTOSE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR; HORMONE RECEPTOR; INCRETIN; INSULIN; PALATINOSE; SUCROSE; SUPPRESSOR OF CYTOKINE SIGNALING 2; UNCLASSIFIED DRUG; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; ISOMALTOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CARBOHYDRATE ABSORPTION; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET SUPPLEMENTATION; FATTY LIVER; GENE EXPRESSION REGULATION; GENE INACTIVATION; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GLYCEMIC INDEX; INSULIN RESISTANCE; LIPID LIVER LEVEL; LIVER PROTECTION; MALE; METABOLIC ACTIVATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPIC VARIATION; POSTPRANDIAL STATE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SUGAR INTAKE; TEST MEAL; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; DIET; INTESTINE ABSORPTION; METABOLISM; PATHOLOGY;

ANIMALS; DIET; FATTY LIVER; GASTRIC INHIBITORY POLYPEPTIDE; INSULIN RESISTANCE; INTESTINAL ABSORPTION; ISOMALTOSE; MALE; MICE; RECEPTORS, GASTROINTESTINAL HORMONE; SUCROSE;

EID: 84922087366     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3423-5     Document Type: Article

References (44)

1. Williams CD, Stengel J, Asike MI et al (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140:124–131
2. Krawczyk M, Bonfrate L, Portincasa P (2010) Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol 24:695–708
3. Marchesini G, Bugianesi E, Forlani G et al (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37:917–923
4. Birkenfeld AL, Shulman GI (2014) Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59:713–723
5. Rudovich NN, Weickert MO, Machann J, Pfeiffer AF (2010) Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: a break of intestinal insulin resistance? J Hepatol 52:952–953
6. Sato K, Arai H, Mizuno A et al (2007) Dietary palatinose and oleic acid ameliorate disorders of glucose and lipid metabolism in Zucker fatty rats. J Nutr 137:1908–1915
7. Daly M (2003) Sugars, insulin sensitivity, and the postprandial state. Am J Clin Nutr 78:865S–872S
8. Kawai K, Yoshikawa H, Murayama Y, Okuda Y, Yamashita K (1989) Usefulness of palatinose as a caloric sweetener for diabetic patients. Horm Metab Res 21:338–340
9. Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO (2010) Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab 298:E287–E295
10. Mortensen K, Christensen LL, Holst JJ, Orskov C (2003) GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114:189–196
11. Yip RG, Wolfe MM (2000) GIP biology and fat metabolism. Life Sci 66:91–103
12. Shimotoyodome A, Suzuki J, Fukuoka D, Tokimitsu I, Hase T (2010) RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice. Am J Physiol Endocrinol Metab 298:E652–E662
13. Musso G, Gambino R, Pacini G, De Michieli F, Cassader M (2009) Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. Am J Clin Nutr 89:558–567
14. Isken F, Weickert MO, Tschop MH et al (2009) Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice. Diabetologia 52:2159–2168
15. Haberer D, Thibault L, Langhans W, Geary N (2009) Beneficial effects on glucose metabolism of chronic feeding of isomaltulose versus sucrose in rats. Ann Nutr Metab 54:75–82
16. Matsuo K, Arai H, Muto K et al (2007) The anti-obesity effect of the palatinose-based formula Inslow is likely due to an increase in the hepatic PPAR-alpha and adipocyte PPAR-gamma gene expressions. J Clin Biochem Nutr 40:234–241
17. Rico-Bautista E, Flores-Morales A, Fernandez-Perez L (2006) Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions. Cytokine Growth Factor Rev 17:431–439
18. Zadjali F, Santana-Farre R, Vesterlund M et al (2012) SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice. FASEB J 26:3282–3291
19. Preitner F, Ibberson M, Franklin I et al (2004) Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 113:635–645
20. Isken F, Klaus S, Osterhoff M, Pfeiffer AF, Weickert MO (2010) Effects of long-term soluble vs. insoluble dietary fiber intake on high-fat diet-induced obesity in C57BL/6J mice. J Nutr Biochem 21:278–284
21. Valentini L, Wirth EK, Schweizer U et al (2009) Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 25:172–181
22. Rainer J, Sanchez-Cabo F, Stocker G, Sturn A, Trajanoski Z (2006) CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res 34:W498–W503
23. Tollet-Egnell P, Flores-Morales A, Stavreus-Evers A, Sahlin L, Norstedt G (1999) Growth hormone regulation of SOCS-2, SOCS-3, and CIS messenger ribonucleic acid expression in the rat. Endocrinology 140:3693–3704
24. Lina BA, Jonker D, Kozianowski G (2002) Isomaltulose (Palatinose): a review of biological and toxicological studies. Food Chem Toxicol 40:1375–1381
25. Arai H, Mizuno A, Matsuo K et al (2004) Effect of a novel palatinose-based liquid balanced formula (MHN-01) on glucose and lipid metabolism in male Sprague-Dawley rats after short- and long-term ingestion. Metabolism 53:977–983
26. Takeda E, Arai H, Yamamoto H, Okumura H, Taketani Y (2005) Control of oxidative stress and metabolic homeostasis by the suppression of postprandial hyperglycemia. J Med Invest 52(Suppl):259–265
27. Park JH, Kwon OD, Ahn SH, Lee S, Choi BK, Jung KY (2013) Fatty diets retarded the propulsive function of and attenuated motility in the gastrointestinal tract of rats. Nutr Res 33:228–234
28. Goff LM, Cowland DE, Hooper L, Frost GS (2013) Low glycaemic index diets and blood lipids: a systematic review and meta-analysis of randomised controlled trials. Nutrition, metabolism, and cardiovascular diseases. Nutr Metab Cardiovasc Dis 23:1–10
29. Kendall DM, Sobel BE, Coulston AM et al (2003) The insulin resistance syndrome and coronary artery disease. Coron Artery Dis 14:335–348
30. Cummings JH, Englyst HN (1995) Gastrointestinal effects of food carbohydrate. Am J Clin Nutr 61:938S–945S
31. Chinda D, Nakaji S, Fukuda S et al (2004) The fermentation of different dietary fibers is associated with fecal clostridia levels in men. J Nutr 134:1881–1886
32. Tonouchi H, Yamaji T, Uchida M et al (2011) Studies on absorption and metabolism of palatinose (isomaltulose) in rats. Br J Nutr 105:10–14
33. Naitoh R, Miyawaki K, Harada N et al (2008) Inhibition of GIP signaling modulates adiponectin levels under high-fat diet in mice. Biochem Biophys Res Commun 376:21–25
34. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA, Flatt PR (2007) GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. Am J Physiol Endocrinol Metab 293:E1746–E1755
35. Knight ZA, Hannan KS, Greenberg ML, Friedman JM (2010) Hyperleptinemia is required for the development of leptin resistance. PLoS One 5:e11376
36. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS (1995) Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1:1311–1314
37. Kadowaki T, Yamauchi T (2005) Adiponectin and adiponectin receptors. Endocr Rev 26:439–451
38. Shimabukuro M, Koyama K, Chen G et al (1997) Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A 94:4637–4641
39. Elam MB, Cowan GS Jr, Rooney RJ et al (2009) Hepatic gene expression in morbidly obese women: implications for disease susceptibility. Obesity (Silver Spring) 17:1563–1573
40. Tateno C, Kataoka M, Utoh R et al (2011) Growth hormone-dependent pathogenesis of human hepatic steatosis in a novel mouse model bearing a human hepatocyte-repopulated liver. Endocrinology 152:1479–1491
41. Fan Y, Menon RK, Cohen P et al (2009) Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism. J Biol Chem 284:19937–19944
42. Umahara M, Okada S, Ohshima K, Mori M (2003) Glucose-dependent insulinotropic polypeptide induced growth hormone secretion in acromegaly. Endocr J 50:643–650
43. Occhi G, Losa M, Albiger N et al (2011) The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells. J Neuroendocrinol 23:641–649
44. Kraus D, Yang Q, Kong D et al (2014) Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature 508:258–262